38 results on '"Chen, Amy Y"'
Search Results
2. Neutrophilic dermatoses: Kids are not just little people.
- Author
-
Lee, Grace L. and Chen, Amy Y-Y.
- Subjects
- *
SKIN inflammation , *NEUTROPHILS , *ETIOLOGY of diseases , *PEDIATRIC therapy , *EXOSTOSIS - Abstract
Neutrophilic dermatoses are a group of inflammatory skin disorders characterized by an overactive innate immune system with dysregulation of neutrophils without underlying infectious etiology. The major representative conditions discussed are Sweet syndrome; pyoderma gangrenosum; neutrophilic eccrine hidradenitis; palmoplantar eccrine hidradenitis; subcorneal pustular dermatoses; bowel-associated dermatosis arthritis syndrome; and synovitis, acne, pustulosis, hyperostosis, and osteitis. We will also discuss other neutrophilic conditions present almost exclusively in the pediatric population, including congenital erosive and vesicular dermatosis with reticulated supple scarring and the recently described group of autoinflammatory diseases. The clinical characteristics, diagnostic approach, and treatment management in the pediatric and adult population are discussed. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
3. Bullous diaper dermatitis with cloth diaper use.
- Author
-
Harfmann, Katya, Chen, Amy Y, and Witman, Patricia
- Subjects
- *
DIAPER rash , *BLISTERS , *IRRITATION (Pathology) , *TODDLERS , *FOLLOW-up studies (Medicine) , *HEALTH - Abstract
Irritant diaper dermatitis occurs at a higher frequency with cloth diaper use than disposable diapers. We present four cases of vesiculobullous, erosive diaper dermatitis occurring in older infants and toddlers with cloth diaper use that resolved completely after transitioning to disposable diapers. This is the first report of vesicles and bullae as a type of irritant diaper dermatitis. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
4. Children and thyroid cancer: Interpreting troubling trends.
- Author
-
Chen, Amy Y. and Davies, Louise
- Subjects
- *
THYROID cancer , *CHILDHOOD cancer , *EPIDEMIOLOGY of cancer , *TRENDS , *DISEASE incidence - Abstract
In this issue, Bernier et al assert that their findings provide evidence that there is a true increase in the incidence of pediatric thyroid cancer, and appear to be working to extend their findings from 2017, in which they came to similar conclusions for the adult population. Although the authors of this editorial agree that a true increase in the incidence of thyroid cancer is possible, and in fact one of them reported in the past on this concern, they also are once again worried that the inferences being drawn from the US cancer epidemiology data may be artifactual. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
5. American Thyroid Association Statement on Optimal Surgical Management of Goiter.
- Author
-
Chen, Amy Y., Bernet, Victor J., Carty, Sally E., Davies, Terry F., Ganly, Ian, Inabnet, William B., and Shaha, Ashok R.
- Subjects
- *
GOITER treatment , *THYROIDECTOMY , *THYROXINE , *HORMONE therapy , *POSTOPERATIVE care , *HYPOPARATHYROIDISM - Abstract
Background: Goiter, or benign enlargement of the thyroid gland, can be asymptomatic or can cause compression of surrounding structures such as the esophagus and/or trachea. The options for medical treatment of euthyroid goiter are short-lived and are limited to thyroxine hormone suppression and radioactive iodine ablation. The objective of this statement article is to discuss optimal surgical management of goiter. Methods: A task force was convened by the Surgical Affairs Committee of the American Thyroid Association and was tasked with writing of this article. Results/Conclusions: Surgical management is recommended for goiters with compressive symptoms. Symptoms of dyspnea, orthopnea, and dysphagia are more commonly associated with thyromegaly, in particular, substernal goiters. Several studies have demonstrated improved breathing and swallowing outcomes after thyroidectomy. With careful preoperative testing and thoughtful consideration of the type of anesthesia, including the type of intubation, preparation for surgery can be optimized. In addition, planning the extent of surgery and postoperative care are necessary to achieve optimal results. Close collaboration of an experienced surgical and anesthesia team is essential for induction and reversal of anesthesia. In addition, this team must be cognizant of complications from massive goiter surgery such as bleeding, airway distress, recurrent laryngeal nerve injury, and transient hypoparathyroidism. With careful preparation and teamwork, successful thyroid surgery can be achieved. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
6. Defining neurotrauma in administrative data using the International Classification of Diseases Tenth Revision.
- Author
-
Chen, Amy Y. and Colantonio, Angela
- Subjects
- *
NERVOUS system injuries , *BRAIN injuries , *SPINAL cord , *INTERNET in medicine ,INTERNATIONAL Statistical Classification of Diseases & Related Health Problems - Abstract
Background: It is essential to use a definition that is precise and accurate for the surveillance of traumatic brain injuries (TBI) and spinal cord injuries (SCI). This paper reviews the International Classification of Diseases 10th revision (ICD-10) definitions used internationally to inform the definition for neurotrauma surveillance using administrative data in Ontario, Canada. Methods: PubMed, Web of Science, Medline and the grey literature were searched for keywords "spinal cord injuries" or "brain injuries" and "international classification of diseases". All papers and reports that used an ICD-10 definition were included. To determine the ICD-10 codes for inclusion consensus across papers and additional evidence were sought to look at the correlation between the condition and brain or spinal injuries. Results: Twenty-four articles and reports were identified; 15 unique definitions for TBI and 7 for SCI were found. The definitions recommended for use in Ontario by this paper are F07.2, S02.0, S02.1, S02.3, S02.7, S02.8, S02.9, S06, S07.1, T90.2, and T90.5 for traumatic brain injuries and S14.0, S14.1, S24.0, S24.1, S34.1, S34.0, S34.3, T06.0, T06.1 and T91.3 for spinal cord injuries. Conclusions: Internationally, inconsistent definitions are used to define brain and spinal cord injuries. An abstraction study of data would be an asset in understanding the effects of inclusion and exclusion of codes in the definition. This paper offers a definition of neurotrauma for surveillance in Ontario, but the definition could be applied to other countries that have mandated administrative data collection. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
7. Improved Survival Is Associated With Treatment at High-Volume Teaching Facilities for Patients With Advanced Stage Laryngeal Cancer.
- Author
-
Chen, Amy Y., Fedewa, Stacey, Pavluck, Alex, and Ward, Elizabeth M.
- Subjects
- *
CANCER research , *LARYNGEAL cancer , *SURVIVAL analysis (Biometry) , *CANCER treatment , *ONCOLOGIC surgery - Abstract
The article presents information on a study which investigated the relation between the number of patients with advanced laryngeal cancer treated at a facility and survival. The study also identified other factors related to survival among patients with advanced-stage laryngeal cancer who received surgical and nonsurgical treatment. Data analyzed were from the National Cancer Database for patients who were diagnosed with advanced-stage laryngeal cancer between 1996 and 2002. The findings of the study are presented and discussed in detail.
- Published
- 2010
- Full Text
- View/download PDF
8. Insurance Status and Survival Disparities Among Nonelderly Rectal Cancer Patients in the National Cancer Data Base.
- Author
-
Robbins, Anthony S., Chen, Amy Y., Stewart, Andrew K., Staley, Charles A., Virgo, Katherine S., and Ward, Elizabeth M.
- Subjects
- *
RECTAL cancer patients , *CANCER-related mortality , *CANCER patients , *MEDICALLY uninsured persons , *HEALTH outcome assessment - Abstract
The article focuses on a study which examined the insurance status and other factors that influence the survival of patients with rectal cancer. The study included 19,154 patients, aged 18 to 64 years, whose five-year survival were examined in relation to 10 factors including age, sex, race/ethnicity, histologic grade, histologic subtype, neighborhood education, income levels, facility type, stage and treatment. It found that all factors, except age, reduce excess mortality among patients with rectal cancer who have no private insurance.
- Published
- 2010
- Full Text
- View/download PDF
9. Increasing Incidence of Differentiated Thyroid Cancer in the United States, 1988-2005.
- Author
-
Chen, Amy Y., Jemal, Ahmedin, and Ward, Elizabeth M.
- Subjects
- *
MEDICAL research , *THYROID cancer , *TUMORS , *GENDER , *DIAGNOSTIC sex determination - Abstract
The article reports on the study that investigates the trends in increasing incidence of differentiated thyroid cancer by size, race, age, and sex. It indicates that incidence rates has increased for all sizes of tumors and the highest rate of increase among men and women of all ages was for primary tumors less than 1.0 centimeter (cm). It suggests that increased diagnostic scrutiny is not the sole explanation for the increase incidence across all tumor sizes.
- Published
- 2009
- Full Text
- View/download PDF
10. Glomuvenous Malformation in a Boy with Transposition of the Great Vessels: A Case Report and Review of Literature.
- Author
-
Chen, Amy Y. Y., Eide, Melody, and Shwayder, Tor
- Subjects
- *
TRANSPOSITION of great vessels , *CONGENITAL heart disease , *AORTA abnormalities , *PEDIATRIC dermatology , *SKIN diseases - Abstract
We report a case of glomuvenous malformation (GVM) in an 11-year-old boy with a history of transposition of the great vessels. The glomulin gene was discovered in 1999, and multiple mutations have been identified with some of the mutations resulting in GVM. The molecular genetics, clinical presentation, histopathology, differential diagnosis, and management of GVM are reviewed. To our knowledge, no case of glomuvenous malformation in the setting of transposition of the great vessels has ever been reported in the literature. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
11. Disparities and Trends in Sentinel Lymph Node Biopsy Among Early-Stage Breast Cancer Patients (1998-2005).
- Author
-
Chen, Amy Y., Halpern, Michael T., Schrag, Nicole M., Stewart, Andrew, Leitch, Maryilyn, and Ward, Elizabeth
- Subjects
- *
BREAST cancer treatment , *BIOPSY , *BREAST cancer patients , *LYMPH nodes , *LOGISTIC regression analysis - Abstract
Background Sentinel lymph node biopsy (SLNB), an acceptable alternative to axillary lymph node dissection for staging patients with breast cancer, was introduced to clinical practice in the late 1990s. We assessed demo- graphic, clinical, and facility-related factors associated with SLNB in women with early-stage breast cancer and evaluated trends in these factors over time. Methods Data on early-stage breast cancers (T1a, T1b, T1c, and T2N0) diagnosed between January 1, 1998, and December 31, 2005, were extracted from the National Cancer Database, a hospital-based registry. Patient demographics, tumor stage, type of lymph node surgery, type of breast cancer surgery, health insurance, treatment facility type, and area-level education and income variables were collected. Multivariable logistic regression analyses were performed to assess predictive factors associated with SLNB, temporal differences in factors associated with SLNB, and differences in rates of SLNB by facility type, race/ethnicity, and type of health insurance over time. Results The total analytic study population included 490899 women. The use of SLNB increased from 26.8% in 1998 to 65.5% in 2005. Factors associated with lower likelihood of SLNB over the study period included being older (odds ratio [OR] = 0.80, 95% confidence interval [CI] = 0.78 to 0.92 for those aged 72 or older compared with those aged 51 or younger), being of racial/ethnic minority (OR = 0.76, 95% Cl = 0.74 to 0.78 for African Americans compared with whites), having no health insurance (OR = 0.77, 95% Cl = 0.73 to 0.80 for uninsured compared with having private insurance), having certain government insurance plans (for Medicaid, OR = 0.81, 95% Cl = 0.78 to 0.84, and for Medicare at age <65 years, OR = 0.83, 95% Cl = 0.80 to 0.87, both compared with private insurance), residing in zip codes with lower proportion of high school graduates (OR = 0.88, 95% Cl = 0.86 to 0.89) or with lower median income (OR = 0.79, 95% Cl = 0.77 to 0.81), and receiving treatment in facility types other than a teaching or research hospital (for community hospital, OR = 0.84, 95% Cl = 0.82 to 0.86; for community cancer center, OR = 0.86, 95% Cl = 0.84 to 0.87). The associations with insurance status and sociodemographic characteristics were more pronounced in 2005 than in 1998. For example, the adjusted annual rates of SLNB in 1998 were 0.29 in whites, 0.26 in African Americans, and 0.35 in Hispanics; in 2005 the respective rates were 0.70, 0.64, and 0.67. Conclusions Although use of SLNB increased from 1998 to 2005, disparities persisted in receipt of SLNB that are based on nonclinical factors, including sociodemographic characteristics and insurance status. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
12. Polarized hyperspectral microscopic imaging system for enhancing the visualization of collagen fibers and head and neck squamous cell carcinoma.
- Author
-
Ximing Zhou, Ling Ma, Mubarak, Hasan K., Palsgrove, Doreen, Sumer, Baran D., Chen, Amy Y., and Baowei Fei
- Subjects
- *
HYPERSPECTRAL imaging systems , *SQUAMOUS cell carcinoma , *POLARIZERS (Light) , *STOKES parameters , *DATA visualization , *COLLAGEN , *NECK - Abstract
Significance: Polarized hyperspectral microscopes with the capability of full Stokes vector imaging have potential for many biological and medical applications. Aim: The aim of this study is to investigate polarized hyperspectral imaging (PHSI) for improving the visualization of collagen fibers, which is an important biomarker related to tumor development, and improving the differentiation of normal and tumor cells on pathologic slides. Approach: We customized a polarized hyperspectral microscopic imaging system comprising an upright microscope with a motorized stage, two linear polarizers, two liquid crystal variable retarders (LCVRs), and a compact SnapScan hyperspectral camera. The polarizers and LCVRs worked in tandem with the hyperspectral camera to acquire polarized hyperspectral images, which were further used to calculate four Stokes vectors: S0, S1, S2, and S3. Synthetic RGB images of the Stokes vectors were generated for the visualization of cellular components in PHSI images. Regions of interest of collagen, normal cells, and tumor cells in the synthetic RGB images were selected, and spectral signatures of the selected components were extracted for comparison. Specifically, we qualitatively and quantitatively investigated the enhanced visualization and spectral characteristics of dense fibers and sparse fibers in normal stroma tissue, fibers accumulated within tumors, and fibers accumulated around tumors. Results: By employing our customized polarized hyperspectral microscope, we extract the spectral signatures of Stokes vector parameters of collagen as well as of tumor and normal cells. The measurement of Stokes vector parameters increased the image contrast of collagen fibers and cells in the slides. Conclusions: With the spatial and spectral information from the Stokes vector data cubes (S0, S1, S2, and S3), our PHSI microscope system enhances the visualization of tumor cells and tumor microenvironment components, thus being beneficial for pathology and oncology. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
13. Effects of socioeconomic status on enrollment in clinical trials for cancer: A systematic review.
- Author
-
Donzo, Maja Wichhart, Nguyen, Grace, Nemeth, John K., Owoc, Maryanna S., Mady, Leila J., Chen, Amy Y., and Schmitt, Nicole C.
- Subjects
- *
SOCIOECONOMIC status , *CLINICAL trials , *DATABASE searching , *MEDICAL librarians , *ZIP codes - Abstract
Background: To achieve equitable access to cancer clinical trials (CCTs), patients must overcome structural, clinical, and attitudinal barriers to trial enrollment. The goal of this systematic review was to study the relationship between socioeconomic status(SES), assessed either by direct or proxy measures, and CCT enrollment. Methods: The review team and medical librarian developed search strategies for each database to identify studies for this systematic review, which was conducted according to PRISMA guidelines. Inclusion criteria were as follows: studies published in relevant scientific journals between January 2000 and July 2022, primary sources, English literature, and studies conducted in the US. Sixteen studies fulfilled the inclusion criteria and were reviewed. The risk of bias assessment was conducted independently by two reviewers using the Newcastle Ottawa scale. Results: The initial search yielded 4070 citations, and 16 studies were included in our review. Four of the studies included used patient reported annual income as a measure of SES, while the remaining 12 studies used patient zip code as a proxy measurement of SES. Consistent with our hypothesis, 13 studies showed a positive association between high SES (patient-reported or proxy measurement) and CCT enrollment. Two studies showed a negative association, and one study showed no relationship. Conclusions: The existing literature suggests that low SES is associated with lower participation in CCT. The small number of studies identified on this topic highlights the need for additional research on SES and other barriers to CCT participation. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
14. Open Access in biomedical sciences: What the current turning point means more specifically to Oral Oncology contributors and readers.
- Author
-
Cohen, Ezra, Chen, Amy Y., Ferris, Robert L., Lee, Anne, and Bernier, Jacques
- Published
- 2013
- Full Text
- View/download PDF
15. Re: "Routine Preoperative Laryngoscopy for Thyroid Surgery Is Not Necessary Without Risk Factors" by Maher et al. (Thyroid 2019;29:1646–1652. DOI: 10.1089/thy.2019.0145).
- Author
-
Walgama, Evan, Sinclair, Catherine, Chen, Amy Y., Davies, Louise, Noel, Julia E., Orloff, Lisa A., Shindo, Maisie, Sigston, Elizabeth, Stack, Brendan C., Terris, David, and Randolph, Gregory W.
- Subjects
- *
LARYNGOSCOPY , *SURGERY , *VOCAL cords - Abstract
It is well established that patients with thyroid malignancy, especially those with posterior extrathyroidal extension or central compartment neck metastases, are at greater risk for recurrent laryngeal nerve invasion. Patients with incomplete VCPs commonly have electrical electromyogram (EMG) signal in the "normal" range and patients with complete VCPs can still exhibit EMG signal to direct nerve stimulation. References 1 Maher DI, Goare S, Forrest E, Grodski S, Serpell JW, Lee JC2019Routine preoperative laryngoscopy for thyroid surgery is not necessary without risk factors. [Extracted from the article]
- Published
- 2020
- Full Text
- View/download PDF
16. Fluorescence In Situ Hybridization.
- Author
-
Chen, Amy Y-Y and Chen, Andrew
- Subjects
- *
FLUORESCENCE in situ hybridization , *FLUORESCENCE microscopy , *DERMATOLOGY , *CYTOGENETICS , *HUMAN skin color , *SKIN diseases - Abstract
The article discusses the concept, application, advantages, and limitations of fluorescence in situ hybridization (FISH) technique in dermatology. It explains that the cytogenetic technique is used to visualize specific cytogenetic abnormalities and can serve as a supplementary diagnostic tool in pigmented lesions but cannot replace traditional histopathologic analysis. It also notes that the limitations of FISH include its cutoff signals, probe designs, and processing errors.
- Published
- 2013
- Full Text
- View/download PDF
17. A Multicenter Randomized Phase II Study of Single Agent Efficacy and Optimal Combination Sequence of Everolimus and Pasireotide LAR in Advanced Thyroid Cancer.
- Author
-
Bauman, Julie E., Chen, Zhengjia, Zhang, Chao, Ohr, James P., Ferris, Robert L., McGorisk, Gerald M., Brandt, Stephen, Srivatsa, Sumathi, Chen, Amy Y., Steuer, Conor E., Shin, Dong M., Saba, Nabil F., Khuri, Fadlo R., and Owonikoko, Taofeek K.
- Subjects
- *
THERAPEUTIC use of antineoplastic agents , *DRUG efficacy , *THYROID gland tumors , *RANDOMIZED controlled trials , *CANCER patients , *INTRAMUSCULAR injections , *EVEROLIMUS , *SOMATOSTATIN , *CONTROLLED release preparations , *DESCRIPTIVE statistics , *SURVIVAL analysis (Biometry) , *STATISTICAL sampling , *PROGRESSION-free survival , *EVALUATION - Abstract
Simple Summary: Prior clinical studies showed modest activity for single agent everolimus and somatostatin analogues in different subtypes of thyroid cancer; the combination of everolimus and somatostatin analogue was synergistic in preclinical models of thyroid cancer. This randomized trial showed that the combination was more effective than a single agent and the sequence of single agent everolimus followed by the delayed combination of everolimus and pasireotide-LAR achieved the best efficacy and was the optimal combination strategy. Purpose: Aberrant mTOR pathway and somatostatin receptor signaling are implicated in thyroid cancer and offer potential therapeutic targets. We assessed the clinical efficacy of everolimus and Pasireotide long-acting release (LAR) in radioiodine-refractory differentiated thyroid cancer (DTC) and medullary thyroid cancer (MTC). Patients and methods: Adults with progressive MTC and DTC untreated or treated with no more than one systemic agent were eligible. The trial was designed to establish the most promising regimen and the optimal combination sequence. Patients were randomized to start treatment with single agent everolimus (10 mg QD; Arm A), pasireotide-LAR (60 mg intramuscular injection, Q4 weeks; Arm B), or the combination (Arm C). At initial progression (PFS1), patients on Arm A or B switched to the combination and continued until progression (PFS2). Efficacy was measured by RECIST criteria. Results: Study enrolled 42 patients: median age 65 years; female 17 (40.5%); White 31 (73.8%), African American 6 (14.3%), others 5 (11.9); DTC 32 (76.2%); MTC 10 (23.8%). There was no objective response by RECIST criteria across the three arms. Median and 1-year PFS1 rates were 8.3, 1.8, 8.1 months and 49.9%, 36.4%, 25.0% for Arms A, B, C, respectively. Median and 1-year PFS2 rates were 26.3, 17.5, 8.1 months and 78.4%, 70.0%, 25% for Arms A, B, C, respectively. The most frequent adverse events were anemia, stomatitis, fatigue, hyperglycemia, and hypercholesterolemia. Conclusions: The combination of everolimus and pasireotide-LAR showed promising efficacy over single agent. The delayed combination of everolimus and pasireotide-LAR following progression on single agent everolimus appeared intriguing as a combination strategy. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
18. Automatic detection of head and neck squamous cell carcinoma on histologic slides using hyperspectral microscopic imaging (Erratum).
- Author
-
Ma, Ling, Little, James V., Chen, Amy Y., Myers, Larry, Sumer, Baran D., and Fei, Baowei
- Subjects
- *
SQUAMOUS cell carcinoma , *NECK , *PERSONAL names , *HEAD - Abstract
The erratum corrects the name of the first author listed in a reference cited. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
19. Automatic detection of head and neck squamous cell carcinoma on histologic slides using hyperspectral microscopic imaging.
- Author
-
Ma, Ling, Little, James V., Chen, Amy Y., Myers, Larry, Sumer, Baran D., and Fei, Baowei
- Subjects
- *
SQUAMOUS cell carcinoma , *NECK , *HYPERSPECTRAL imaging systems , *CONVOLUTIONAL neural networks , *HEAD & neck cancer , *SUPPORT vector machines - Abstract
Significance: Automatic, fast, and accurate identification of cancer on histologic slides has many applications in oncologic pathology. Aim: The purpose of this study is to investigate hyperspectral imaging (HSI) for automatic detection of head and neck cancer nuclei in histologic slides, as well as cancer region identification based on nuclei detection. Approach: A customized hyperspectral microscopic imaging system was developed and used to scan histologic slides from 20 patients with squamous cell carcinoma (SCC). Hyperspectral images and red, green, and blue (RGB) images of the histologic slides with the same field of view were obtained and registered. A principal component analysis-based nuclei segmentation method was developed to extract nuclei patches from the hyperspectral images and the coregistered RGB images. Spectra-based support vector machine and patch-based convolutional neural networks (CNNs) were implemented for nuclei classification. The CNNs were trained with RGB patches (RGB-CNN) and hyperspectral patches (HSI-CNN) of the segmented nuclei and the utility of the extra spectral information provided by HSI was evaluated. Furthermore, cancer region identification was implemented by image-wise classification based on the percentage of cancerous nuclei detected in each image. Results: RGB-CNN, which mainly used the spatial information of nuclei, resulted in a 0.81 validation accuracy and 0.74 testing accuracy. HSI-CNN, which utilized the spatial and spectral features of the nuclei, showed significant improvement in classification performance and achieved 0.89 validation accuracy as well as 0.82 testing accuracy. Furthermore, the image-wise cancer region identification based on nuclei detection could generally improve the cancer detection rate. Conclusions: We demonstrated that the morphological and spectral information contribute to SCC nuclei differentiation and that the spectral information within hyperspectral images could improve classification performance. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
20. Qualitative Study of Mentorship for Women and Minorities in Surgery.
- Author
-
Mahendran, Geethanjeli N., Walker, Elizabeth Reisinger, Bennett, Mackenzie, and Chen, Amy Y.
- Subjects
- *
MENTORING , *MEDICAL students , *CAREER development , *GENDER identity , *MINORITY students , *MINORITIES , *INTERNSHIP programs - Abstract
Background: Despite the growth of mentorship opportunities for women in surgery, women remain largely underrepresented in the surgical field. Mentorship is an effective strategy to increase female entry and retention within surgical careers. There is limited literature evaluating mentorship for women in surgery across different career levels and racial backgrounds.Study Design: In-depth interviews were conducted with female fourth-year medical students applying for a surgical residency, female surgical residents, and female surgical faculty from a single academic institution.Results: A total of 35 women in surgery, including 14 faculty, 11 residents, and 10 fourth-year medical students were interviewed. Twenty (57%) self-identified as White, 7 (20%) as Asian, 6 (17.1%) as Black, and 2 (5.7%) as Other. Key themes included: (1) access to mentorship, (2) characteristics valued in a mentor, (3) role of gender identity when choosing a mentor, (4) role of racial identity when choosing a mentor, and (5) importance of early mentorship for women and underrepresented minorities in medicine (URiM). Mentorship was important for early career development. Mentors who were approachable, invested in their mentees, and were available and honest were most valued. Shared gender and racial identity were appreciated most by younger and URiM mentees, respectively. Respondents from each career level acknowledged the importance of early mentorship for women and URiM in surgery to facilitate increased diversity in the surgical field.Conclusion: Mentorship plays a pivotal role in early career development for women in the surgical field. Access to mentors with shared gender and racial compositions can provide a unique level of support for female and URiM mentees. Expanded and earlier mentorship access for women and minority students can increase diversity in the surgical field. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
21. The value of tumor diameter in predicting prognosis of oropharynx cancer treated with chemoradiation
- Author
-
Ward, Matthew C., Lan, Ling, Chen, Amy Y., and Beitler, Jonathan J.
- Subjects
- *
PHARYNGEAL cancer , *OROPHARYNX , *CANCER chemotherapy , *METASTASIS , *TUMOR growth , *RETROSPECTIVE studies , *FOLLOW-up studies (Medicine) , *CANCER radiotherapy , *PROGNOSIS - Abstract
Summary: Objectives: The tumor node metastasis (TNM) system is the most widely used staging system for cancers of the oropharynx, yet is known to omit key prognostic indicators. Tumor volume has been shown in other head and neck sites to add predictive power but is not as useful in the oropharynx. This study investigates the value of other methods in quantifying tumor burden. Methods: Treatment plans of oropharyngeal cancer patients treated non-operatively were retrospectively reviewed. Potential prognostic factors including TNM, demographics, smoking history, and various tumor dimensions were analyzed. Results: Records identified 93 patients treated with definitive concurrent chemoradiation who had at least one year of follow-up and a clear GTV contour on the original treatment plan. On univariate analysis, tumor diameter and tumor volume showed a significant relationship to overall and disease-free survival. Tumor stage, age and smoking history showed significance in regard to overall survival. On multivariate analysis tumor diameter showed independent significance but not TNM or tumor volume. Conclusion: Our method of measuring tumor diameter has independent prognostic significance in the oropharynx where GTV has shown questionable value. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
22. Patterns of extralaryngeal spread of laryngeal cancer.
- Author
-
Chen, Susie A., Muller, Susan, Chen, Amy Y., Hudgins, Patricia A., Shin, Dong M., Khuri, Fadlo, Saba, Nabil F., and Beitler, Jonathan J.
- Subjects
- *
LARYNGEAL cancer , *SQUAMOUS cell carcinoma , *LARYNGECTOMY , *LARYNGEAL surgery , *TOMOGRAPHY , *HEAD & neck cancer - Abstract
BACKGROUND: Laryngeal preservation programs for patients with advanced laryngeal squamous cell carcinomas (SCC) have generally excluded patients with T4 disease. The accuracy of preoperative imaging in evaluating thyroid cartilage penetration and extralaryngeal spread (ELS) has previously been questioned. Clinically, SCC spread into noncartilaginous structures may have less of a functional impact when compared with thyroid cartilage penetration. The current study was designed to characterize and quantify the routes and frequency of ELS. METHODS: A total of 103 laryngectomy specimens with preoperative contrast-enhanced neck computed tomography scans were coded according to the observed extent of disease by pathological and radiological data. Previously irradiated tumors or those of pyriform sinus origin were omitted. Routes of spread were categorized as anterior (thyroid cartilage penetration), posterior (arytenoid cartilage destruction and thyroarytenoid space widening), inferior (conus elasticus penetration), and superior (base of tongue, thyrohyoid membrane or thyroid notch penetration involvement). RESULTS: Sixty-three cases of ELS were identified. Anterior spread by thyroid cartilage penetration occurred in 44% of all instances of ELS, followed by both inferior and posterior spread each representing 33% of ELS cases. Superior spread occurred with a frequency of 24%. CONCLUSIONS: Although thyroid cartilage penetration is a common route of ELS of glottic and supraglottic SCC, ELS into surrounding structures with thyroid cartilage penetration was found to occur in only 44% of the cases of ELS in the current study. As illustrated, advanced SCC spreads in a variety of pathways. Once these patterns are better understood and identified at the time of initial evaluation, subgroups of patients with ELS who may still be candidates for laryngeal preservation may be identified. Cancer 2011;. © 2011 American Cancer Society. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
23. Histopathology Feature Mining and Association with Hyperspectral Imaging for the Detection of Squamous Neoplasia.
- Author
-
Lu, Guolan, Wang, Dongsheng, Qin, Xulei, Muller, Susan, Little, James V., Wang, Xu, Chen, Amy Y., Chen, Georgia, and Fei, Baowei
- Subjects
- *
ASSOCIATION rule mining , *TUMORS , *HISTOPATHOLOGY , *PREDICTION models , *PATHOLOGICAL physiology - Abstract
Hyperspectral imaging (HSI) is a noninvasive optical modality that holds promise for early detection of tongue lesions. Spectral signatures generated by HSI contain important diagnostic information that can be used to predict the disease status of the examined biological tissue. However, the underlying pathophysiology for the spectral difference between normal and neoplastic tissue is not well understood. Here, we propose to leverage digital pathology and predictive modeling to select the most discriminative features from digitized histological images to differentiate tongue neoplasia from normal tissue, and then correlate these discriminative pathological features with corresponding spectral signatures of the neoplasia. We demonstrated the association between the histological features quantifying the architectural features of neoplasia on a microscopic scale, with the spectral signature of the corresponding tissue measured by HSI on a macroscopic level. This study may provide insight into the pathophysiology underlying the hyperspectral dataset. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
24. Optical biopsy of head and neck cancer using hyperspectral imaging and convolutional neural networks.
- Author
-
Halicek, Martin, Little, James V., Xu Wang, Chen, Amy Y., and Feia, Baowei
- Subjects
- *
HEAD & neck cancer , *ARTIFICIAL neural networks , *MEDULLARY thyroid carcinoma , *SQUAMOUS cell carcinoma , *THYROID cancer - Abstract
For patients undergoing surgical cancer resection of squamous cell carcinoma (SCCa), cancer-free surgical margins are essential for good prognosis. We developed a method to use hyperspectral imaging (HSI), a noncontact optical imaging modality, and convolutional neural networks (CNNs) to perform an optical biopsy of ex-vivo, surgical gross-tissue specimens, collected from 21 patients undergoing surgical cancer resection. Using a cross-validation paradigm with data from different patients, the CNN can distinguish SCCa from normal aerodigestive tract tissues with an area under the receiver operator curve (AUC) of 0.82. Additionally, normal tissue from the upper aerodigestive tract can be subclassified into squamous epithelium, muscle, and gland with an average AUC of 0.94. After separately training on thyroid tissue, the CNN can differentiate between thyroid carcinoma and normal thyroid with an AUC of 0.95, 92% accuracy, 92% sensitivity, and 92% specificity. Moreover, the CNN can discriminate medullary thyroid carcinoma from benign multinodular goiter (MNG) with an AUC of 0.93. Classical-type papillary thyroid carcinoma is differentiated from MNG with an AUC of 0.91. Our preliminary results demonstrate that an HSI-based optical biopsy method using CNNs can provide multicategory diagnostic information for normal and cancerous head-and-neck tissue, and more patient data are needed to fully investigate the potential and reliability of the proposed technique. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
25. Prognostic implications of peritumoral vasculature in head and neck cancer.
- Author
-
Evans, Michael, Baddour Jr, Harry Michael, Magliocca, Kelly R., Müller, Susan, Nannapaneni, Sreenivas, Chen, Amy Y., Kim, Sunjin, Chen, Zhengjia, Shin, Dong M., Wang, Andrew Y., Saba, Nabil F., and Chen, Zhuo G.
- Subjects
- *
HEAD & neck cancer , *SQUAMOUS cell carcinoma , *NECK - Abstract
Background: There is conflicting evidence regarding the role of peritumoral lymphatic vessel density (LVD) and blood microvessel density (MVD) in the metastasis and prognosis of head and neck squamous cell carcinoma (HNSCC). Existing studies are limited to one or two head and neck subsites and/or small sample sizes. A larger study incorporating multiple sub‐sites is needed to address the role of peritumoral LVD and MVD in HNSCC metastasis and prognosis. Methods: Tissue samples from 200 HNSCC cases were stained simultaneously using immunohistochemistry (IHC) for markers of peritumoral LVD (lymphatic vessel marker D240) and MVD (blood vessel marker CD31). Of the stained slides, 166 and 167 were evaluable for LVD and MVD, respectively. The results were then correlated with clinicopathologic features and patient outcomes. Results: Patients with metastatic disease were more likely to have high peritumoral MVD. Through multivariable analyses, MVD was not significantly related to DFS and OS, while low LVD was related to higher risk of disease progression and poor survival. Conclusions: Peritumoral MVD was found to be positively associated with metastasis, while LVD was found to be inversely related to both metastasis and progression of HNSCC. These findings may suggest a prognostic role of both peritumoral LVD and MVD in patients with HNSCC. In the current study, we used a larger sample size which incorporates multiple sub‐sites to address the role of peritumoral LVD and MVD in HNSCC metastasis and prognosis. It was found that peritumoral MVD was positively associated with metastasis, while LVD was inversely related to both metastasis and progression of HNSCC. These findings may suggest a prognostic role of both peritumoral LVD and MVD in patients with HNSCC. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
26. T4 Laryngeal Cancer With Good Function: Should We Be Reluctant to Treat Without Surgery?
- Author
-
Beitler, Jonathan J, Ridge, John A, Vermorken, Jan B, Bradford, Carol R, Strojan, Primož, Saba, Nabil F, Suárez, Carlos, Rodrigo, Juan P, Rinaldo, Alessandra, Chen, Amy Y, and Ferlito, Alfio
- Subjects
- *
LARYNGECTOMY , *LARYNX , *ONCOLOGY ,LARYNGEAL tumors - Published
- 2018
- Full Text
- View/download PDF
27. Treatment and survival vary by race/ethnicity in patients with anaplastic thyroid cancer.
- Author
-
Roche, Ansley M., Fedewa, Stacey A., Shi, Lucy L., and Chen, Amy Y.
- Subjects
- *
THYROID cancer , *ETHNICITY , *SOCIOECONOMIC factors , *CANCER , *EPIDEMIOLOGY - Abstract
Background: Anaplastic thyroid cancer (ATC) is the rarest type of thyroid cancer and has the lowest overall survival. To the authors' knowledge, the impact of socioeconomic status and race/ethnicity has not yet been described.Methods: Data regarding 719 patients diagnosed with their first primary malignant ATC from January 1, 1998 to December 31, 2011 in the Surveillance, Epidemiology, and End Results program registries were examined. Differences in receipt of thyroidectomy, radiotherapy, and lymph node examination were examined by race/ethnicity. Survival also was examined by race/ethnicity.Results: Nearly 70% of patients were non-Hispanic white, and 55.4% of patients received treatment. Tumor size (P = .13), lymph node involvement (P = .60), and residence in high poverty neighborhoods (P = .08) did not vary by race/ethnicity. Nonwhite patients were more likely to receive no treatment (adjusted odds ratio, 0.29; 95% confidence interval [95% CI], 0.16-0.54). When receipt of radiotherapy was adjusted for, nonwhite patients had a higher risk of overall death (adjusted hazards ratio [aHR], 1.24; 95% CI, 1.01-1.54), although not disease-specific death (aHR, 1.14; 95% CI, 0.92-1.42). Patients living in areas of high poverty had lower overall survival (aHR, 1.54; 95% CI, 1.09-2.18) and disease-specific survival (aHR, 1.68; 95% CI, 1.19-2.36).Conclusions: In this population-based study of patients with ATC, nonwhite patients were found to be less likely to receive treatment. Furthermore, nonwhite patients had poorer overall survival, and patients living in areas of high poverty had both worse overall and disease-specific survival. Racial/ethnic and socioeconomic disparities appear to exist in the treatment and survival of patients with ATC. Cancer 2018;124:1780-90. © 2018 American Cancer Society. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
28. Label-free reflectance hyperspectral imaging for tumor margin assessment: a pilot study on surgical specimens of cancer patients.
- Author
-
Baowei Fei, Guolan Lu, Xu Wang, Hongzheng Zhang, Little, James V., Patel, Mihir R., Griffith, Christopher C., El-Diery, Mark W., and Chen, Amy Y.
- Subjects
- *
CANCER prognosis , *CANCER treatment , *CANCER patient medical care , *CELL morphology , *OPTICAL coherence tomography , *HYPERSPECTRAL imaging systems - Abstract
A label-free, hyperspectral imaging (HSI) approach has been proposed for tumor margin assessment. HSI data, i.e., hypercube (x,y,λ), consist of a series of high-resolution images of the same field of view that are acquired at different wavelengths. Every pixel on an HSI image has an optical spectrum. In this pilot clinical study, a pipeline of a machine-learning-based quantification method for HSI data was implemented and evaluated in patient specimens. Spectral features from HSI data were used for the classification of cancer and normal tissue. Surgical tissue specimens were collected from 16 human patients who underwent head and neck (H&N) cancer surgery. HSI, autofluorescence images, and fluorescence images with 2-deoxy-2-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]-D-glucose (2-NBDG) and proflavine were acquired from each specimen. Digitized histologic slides were examined by an H&N pathologist. The HSI and classification method were able to distinguish between cancer and normal tissue from the oral cavity with an average accuracy of 90% ± 8%, sensitivity of 89% ± 9%, and specificity of 91% ± 6%. For tissue specimens from the thyroid, the method achieved an average accuracy of 94% ± 6%, sensitivity of 94% ± 6%, and specificity of 95% ± 6%. HSI outperformed autofluorescence imaging or fluorescence imaging with vital dye (2-NBDG or proflavine). This study demonstrated the feasibility of label-free, HSI for tumor margin assessment in surgical tissue specimens of H&N cancer patients. Further development of the HSI technology is warranted for its application in image-guided surgery. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
29. Deep convolutional neural networks for classifying head and neck cancer using hyperspectral imaging.
- Author
-
Halicek, Martin, Guolan Lu, Little, James V., Xu Wang, Patel, Mihir, Griffith, Christopher C., El-Deiry, Mark W., Chen, Amy Y., and Baowei Fei
- Subjects
- *
HEAD & neck cancer diagnosis , *ONCOLOGIC surgery , *ARTIFICIAL neural networks , *HYPERSPECTRAL imaging systems , *DISEASE remission - Abstract
Surgical cancer resection requires an accurate and timely diagnosis of the cancer margins in order to achieve successful patient remission. Hyperspectral imaging (HSI) has emerged as a useful, noncontact technique for acquiring spectral and optical properties of tissue. A convolutional neural network (CNN) classifier is developed to classify excised, squamous-cell carcinoma, thyroid cancer and normal head and neck tissue samples using HSI. The CNN classification was validated by the manual annotation of a pathologist specialized in head and neck cancer. The preliminary results of 50 patients indicate the potential of HSI and deep learning for automatic tissue- labeling of surgical specimens of head and neck patients. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
30. Comparative effectiveness of surgical and nonsurgical therapy for advanced laryngeal cancer.
- Author
-
Lin, Chun Chieh, Fedewa, Stacey A., Prickett, Kara K., Higgins, Kristin A., and Chen, Amy Y.
- Subjects
- *
LARYNGEAL cancer , *EPIDEMIOLOGY , *LARYNGECTOMY , *CANCER treatment , *MEDICAL care , *COMPARATIVE studies , *REPORTING of diseases , *RESEARCH methodology , *MEDICAL cooperation , *RESEARCH , *EVALUATION research , *TREATMENT effectiveness , *TUMOR treatment ,LARYNGEAL tumors - Abstract
Background: The treatment of patients with advanced stage laryngeal cancer includes surgery or concurrent chemoradiation (CRT). Although CRT has become more common in recent years, to the authors' knowledge, the effectiveness of complete CRT in improving survival over surgery has not been studied.Methods: The authors examined patients in the Surveillance, Epidemiology, and End Results (SEER)-Medicare claims-linked data set with locoregional laryngeal cancer who were diagnosed between 1997 and 2007. Multivariate Cox proportional hazard analyses were conducted to compare overall and cause-specific 5-year survival rates between treatment modalities, adjusting for patient sociodemographic and clinical characteristics. A propensity score-matched subcohort also was used to compare survival.Results: Of the 3212 patients in the study cohort, 42% underwent surgery and 18% underwent CRT. Only approximately one-quarter of patients who were treated with CRT completed the courses. In adjusted analyses, the authors were unable to reject the null hypothesis of no difference in 5-year all-cause or cause-specific mortality risk between patients treated with surgery and patients undergoing complete CRT (hazards ratio, 1.25 [95% confidence interval, 0.91-1.71; P = .16] and hazard ratio, 1.41 [95% confidence interval, 0.9-2.2; P = .14], respectively). Older age, not currently married, Medicaid eligibility, and prior cancer history were found to be associated with a higher risk of mortality (P<.05).Conclusions: Patients with advanced laryngeal cancer who underwent complete CRT were found to have overall and cause-specific survival rates similar to those of patients undergoing surgery. However, a substantial percentage of patients who initiated CRT did not complete the course. Although CRT provides organ preservation, the benefits and trade-offs of CRT and total laryngectomy should be discussed fully with patients. The importance of completing the full course of CRT should be emphasized. Cancer 2016. © 2016 American Cancer Society. Cancer 2016;122:2845-2856. © 2016 American Cancer Society. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
31. Phase 1 and pharmacokinetic study of everolimus in combination with cetuximab and carboplatin for recurrent/metastatic squamous cell carcinoma of the head and neck.
- Author
-
Saba, Nabil F., Hurwitz, Selwyn J., Magliocca, Kelly, Kim, Sungjin, Owonikoko, Taofeek K., Harvey, Donald, Ramalingam, Suresh S., Chen, Zhengjia, Rogerio, Jackie, Mendel, Jennifer, Kono, Scott A., Lewis, Colleen, Chen, Amy Y., Higgins, Kristin, El‐Deiry, Mark, Wadsworth, Trad, Beitler, Jonathan J., Shin, Dong M., Sun, Shi‐Yong, and Khuri, Fadlo R.
- Subjects
- *
SQUAMOUS cell carcinoma , *EVEROLIMUS , *CETUXIMAB , *CARBOPLATIN , *PHARMACOKINETICS , *CANCER relapse , *HEAD & neck cancer treatment , *THERAPEUTICS , *CANCER treatment - Abstract
BACKGROUND Platinum-based therapy combined with cetuximab is standard first-line therapy for recurrent or metastatic squamous cell carcinoma of the head and neck (RMSCCHN). Preclinical studies have suggested that mammalian target of rapamycin inhibitors may overcome resistance to epidermal growth factor receptor blockers and may augment cetuximab antitumor activity. We conducted a phase 1b trial of carboplatin, cetuximab, and everolimus for untreated RMSCCHN. METHODS Patients received carboplatin (area under the curve = 2 mg/ml/min; 3 weeks on, 1 week off), cetuximab (with a loading dose of 400 mg/m2 and then 250 mg/m2 weekly), and dose-escalating everolimus (2.5, 5.0, 7.5, and 10 mg/day) with a 3+3 design. After 4 cycles, patients without progression continued cetuximab/everolimus until progression or intolerable toxicity. Patients (age ≥ 18 years) had previously untreated, unresectable RMSCCHN not amenable to radiotherapy and an Eastern Cooperative Oncology Group performance status of 0 to 2. RESULTS The study enrolled 20 patients (male/female = 18/2) with RMSCCHN; the median age was 65 years (44-75 years). Thirteen patients received everolimus (male/female = 92%). Two of 6 patients receiving 2.5 mg/day experienced dose-limiting toxicity (DLT) with grade 3 hyponatremia and nausea. In 7 patients receiving de-escalated everolimus (2.5 mg every other day), grade 3 hyperglycemia produced DLT in 1 of 6 patients. The objective response rate (RR) was 61.5% (all partial responses). Progression-free survival (PFS) was 8.15 months. The pharmacokinetics of everolimus was described with a 2-compartment mixed-effects model. There was a significant correlation between tumor p-p44/42 staining and response ( P = .044) and a marginally significant correlation between phosphorylated mammalian target of rapamycin and overall survival. CONCLUSIONS The maximum tolerated dose of everolimus with cetuximab and carboplatin was 2.5 mg every other day. The regimen was associated with an encouraging RR and PFS, and this suggested possible clinical efficacy in a select group of patients with squamous cell carcinoma of the head and neck. Cancer 2014;120:3940-3951. © 2014 American Cancer Society. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
32. Paranasal sinus squamous cell carcinoma incidence and survival based on Surveillance, Epidemiology, and End Results Data, 1973 to 2009.
- Author
-
Ansa, Benjamin, Goodman, Michael, Ward, Kevin, Kono, Scott A., Owonikoko, Taofeek K., Higgins, Kristin, Beitler, Jonathan J., Grist, William, Wadsworth, Trad, El‐Deiry, Mark, Chen, Amy Y., Khuri, Fadlo Raja, Shin, Dong M., and Saba, Nabil F.
- Subjects
- *
PARANASAL sinuses , *SQUAMOUS cell carcinoma , *HEAD & neck cancer , *CONFIDENCE intervals , *MORTALITY , *HEALTH of African Americans , *CANCER - Abstract
BACKGROUND Paranasal sinus squamous cell carcinomas (PNSSCC) account for 3% of all head and neck malignancies. There has been little information on the trends in incidence and survival, and no randomized trials have been conducted to guide therapy. METHODS Patients with PNSSCC reported to the Surveillance, Epidemiology, and End Results (SEER) Program from 1973 through 2009 were categorized by sex, age, year of diagnosis, primary site, stage, and treatment. The incidence and survival were then compared across different demographic and disease-related categories by calculating rate ratios (RRs) and mortality hazard ratios along with the corresponding 95% confidence intervals (CIs). RESULTS In total, 2553 patients with PNSSCC were identified. While incidence of PNSSCC showed a gradual decline, survival remained largely unchanged. The proportion of patients with advanced disease decreased from 14.7% during the period from 1983 to 1992 to 12.4% during 1993-2002 and to 9.5% during 2003-2009. Compared with whites, incidence was higher among African Americans (RR 1.63; 95% CI, 1.39, 1.90) and among all other racial groups (RR, 1.78; 95% CI: 1.53-2.07). After adjusting for age, sex, disease stage, tumor site, and treatment, mortality among African American patients also was increased (hazard ratio, 1.22; 95% CI, 1.04-1.43). Among patients with localized disease, the relation between race and mortality was no longer evident once the results were controlled for tumor classification. CONCLUSIONS The current findings point to racial disparities in the incidence of PNSSCC and, to a lesser extent, in the outcome of patients with PNSSCC. Although there has been a decline in the proportion of patients presenting with advanced PNSSCC, the overall survival remained stable over time. Cancer 2013;119:2602-2610. © 2013 American Cancer Society. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
33. Coffee, Tea, and Fatal Oral/Pharyngeal Cancer in a Large Prospective US Cohort.
- Author
-
Hildebrand, Janet S., Patel, Alpa V., Mccullough, Marjorie L., Gaudet, Mia M., Chen, Amy Y., Hayes, Richard B., and Gapstur, Susan M.
- Subjects
- *
CAFFEINE , *COFFEE , *CONFIDENCE intervals , *STATISTICAL correlation , *DOSE-response relationship in biochemistry , *DRINKING (Physiology) , *LONGITUDINAL method , *MOUTH tumors , *QUESTIONNAIRES , *RESEARCH funding , *TEA , *DEATH certificates , *SECONDARY analysis , *RELATIVE medical risk , *PROPORTIONAL hazards models , *DESCRIPTIVE statistics ,PHARYNX tumors - Abstract
Epidemiologic studies suggest that coffee intake is associated with reduced risk of oral/pharyngeal cancer. The authors examined associations of caffeinated coffee, decaffeinated coffee, and tea intake with fatal oral/pharyngeal cancer in the Cancer Prevention Study II, a prospective US cohort study begun in 1982 by the American Cancer Society. Among 968,432 men and women who were cancer free at enrollment, 868 deaths due to oral/pharyngeal cancer occurred during 26 years of follow-up. Cox proportional hazards regression was used to estimate multivariable-adjusted relative risk. Intake of >4 cups/day of caffeinated coffee was associated with a 49% lower risk of oral/pharyngeal cancer death relative to no/occasional coffee intake (relative risk = 0.51, 95% confidence interval: 0.40, 0.64) (1 cup/day = 237 ml). A dose-related decline in relative risk was observed with each single cup/day consumed (Ptrend < 0.001). The association was not modified by sex, smoking status, or alcohol use. An inverse association for >2 cups/day of decaffeinated coffee intake was suggested (relative risk = 0.61, 95% confidence interval: 0.37, 1.01). No association was found for tea drinking. In this large prospective study, caffeinated coffee intake was inversely associated with oral/pharyngeal cancer mortality. Research is needed to elucidate biologic mechanisms whereby coffee might help to protect against these often fatal cancers. [ABSTRACT FROM PUBLISHER]
- Published
- 2013
- Full Text
- View/download PDF
34. Adenoid cystic carcinoma of the head and neck.
- Author
-
Ellington, Christopher L., Goodman, Michael, Kono, Scott A., Grist, William, Wadsworth, Trad, Chen, Amy Y., Owonikoko, Taofeek, Ramalingam, Suresh, Shin, Dong M., Khuri, Fadlo R., Beitler, Jonathan J., and Saba, Nabil F.
- Subjects
- *
ADENOID cystic carcinoma , *HEAD & neck cancer treatment , *SALIVARY gland tumors , *CONFIDENCE intervals , *HEALTH outcome assessment , *COMPARATIVE studies , *THERAPEUTICS - Abstract
BACKGROUND: Adenoid cystic carcinoma (ACC) of the head and neck (ACCHN) is a rare tumor of minor salivary, parotid, and submandibular glands. The biologic behavior of the disease is poorly understood, and nonsurgical treatment strategies have yet to be standardized. The long-term prognosis continues to be guarded, with an estimated 10-year survival of <60%. Population-based studies examining ACC are scarce. The authors aimed to analyze incidence rates and survival outcomes for patients diagnosed with ACCHN using national population-based data. METHODS: Data were obtained from the US National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) program. Newly diagnosed ACCHN cases reported to SEER from 1973 through 2007 were categorized according to their sex, race, age, year of diagnosis, marital status, treatment interventions, primary tumor site, and disease stage. Incidence of ACCHN and postdiagnosis survival were examined over time and compared across different demographic and disease-related categories. RESULTS: The authors identified 3026 patients with ACCHN. The mean age at diagnosis among those cases was 57.4 years (range, 11-99 years). Analyses of incidence data demonstrated a decline in ACCHN rates between 1973 and 2007, noted across all sexes and races with no detectable inflexion points. The overall 5-year, 10-year, and 15-year survival outcomes for ACCHN patients were 90.3%, 79.9%, and 69.2%, respectively. Females, patients with localized disease, and younger patients were found to have significantly better survival across all time periods (all comparison-specific log-rank P values <0.001). Multivariate analyses revealed better prognosis among women compared with men (hazard ratio [HR], 0.73; 95% confidence interval [CI], 0.65-0.82), among married compared with unmarried individuals (HR, 0.81; 95% CI, 0.71-0.91), with certain sites of origin and stage of disease (HR, 2.788; 95% CI, 2.36-3.29), and in those who had surgery of the primary tumor site (HR, 0.45; 95% CI, 0.37-0.54). CONCLUSIONS: The overall incidence of ACC is declining. The noted differences in survival based on sex, marital status, site of origin, and treatment intervention require further investigation. Cancer 2012. © 2012 American Cancer Society [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
35. Safety-Net Burden Hospitals and Likelihood of Curative-Intent Surgery for Non-Small Cell Lung Cancer
- Author
-
Virgo, Katherine S., Little, Alex G., Fedewa, Stacey A., Chen, Amy Y., Flanders, W. Dana, and Ward, Elizabeth M.
- Subjects
- *
LUNG cancer , *ONCOLOGIC surgery , *CANCER patients , *CANCER diagnosis , *CANCER invasiveness , *LINEAR statistical models - Abstract
Background: Black patients are less likely to undergo surgery for early-stage non-small cell lung cancer (NSCLC) compared with white patients, and are more likely to undergo resection at low-volume hospitals. However, little is known about the relationship between hospital safety-net burden and the likelihood of curative-intent surgery for black and white patients. This study analyzes whether hospital safety-net burden is associated with curative-intent surgery among adult early-stage NSCLC patients treated at facilities accredited by the American College of Surgeons Commission on Cancer. Study Design: Adult patients diagnosed with invasive initial primary early-stage (TNM I–II) NSCLC during 2003-2005 were obtained from the National Cancer Data Base. Curative-intent surgery included anatomic resection, wedge resection, and segmentectomy. Hospital safety-net burden was defined as the percent of cancer patients per facility that were Medicaid-insured or uninsured. Generalized estimating equations and linear mixed models were used to control for clustering by facility. Results: Of 52,853 evaluable patients, those treated at high safety-net burden facilities were significantly less likely (unadjusted p < 0.0001) to undergo curative-intent surgery than patients treated at low safety-net burden facilities. Controlling for patient and other facility characteristics, high safety-net burden remained significantly associated (p < 0.0001) with reduced likelihood of curative-intent surgery overall (odds ratio = 0.69; 95% CI, 0.62−0.77) and in black- and white-only models (odds ratio = 0.59, 95% CI, 0.48−0.73; odds ratio = 0.71; 95% CI, 0.63−0.80, respectively). Conclusions: Both black and white adult patients treated for early-stage NSCLC at high safety-net burden facilities are less likely to undergo curative-intent surgery than those treated at low safety-net burden facilities. Innovative solutions are needed to ensure quality cancer care at high safety-net burden facilities. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
36. Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis
- Author
-
Halpern, Michael T, Ward, Elizabeth M, Pavluck, Alexandre L, Schrag, Nicole M, Bian, John, and Chen, Amy Y
- Subjects
- *
HEALTH insurance , *CANCER patients , *MEDICAL screening , *MINORITIES - Abstract
Summary: Background: Individuals in the USA without private medical insurance are less likely to have access to medical care or participate in cancer screening programmes than those with private medical insurance. Smaller regional studies in the USA suggest that uninsured and Medicaid-insured individuals are more likely to present with advanced-stage cancer than privately insured patients; however, this finding has not been assessed using contemporary, national-level data. Furthermore, patients with cancer from ethnic minorities are more likely to be uninsured or Medicaid-insured than non-Hispanic white people. Separating the effects on stage of cancer at diagnosis associated with these two types of patient characteristics can be difficult. Methods: Patients with cancer in the USA, diagnosed between 1998 and 2004, were identified using the US National Cancer Database—a hospital-based registry that contains patient information from about 1430 facilities. Odds ratios and 95% CIs for the effect of insurance status (Medicaid, Medicare (65–99 years), Medicare (18–64 years), private, or uninsured) and ethnicity (white, Hispanic, black, or other) on disease stage at diagnosis for 12 cancer sites (breast [female], colorectal, kidney, lung, melanoma, non-Hodgkin lymphoma, ovary, pancreas, prostate, urinary bladder, uterus, and thyroid) were estimated, while controlling for patient characteristics. Findings: 3 742 407 patients were included in the analysis; patient characteristics were similar to those of the corresponding US population not included in the analysis. Uninsured and Medicaid-insured patients were significantly more likely to present with advanced-stage cancer compared with privately insured patients. This finding was most prominent for patients who had cancers that can potentially be detected early by screening or symptom assessment (eg, breast, colorectal, and lung cancer, as well as melanoma). For example, the odds ratios for advanced-stage disease (stage III or IV) at diagnosis for uninsured or Medicaid-insured patients with colorectal cancer were 2·0 (95% CI 1·9–2·1) and 1·6 (95% CI 1·5–1·7), respectively, compared with privately-insured patients. For advanced-stage melanoma, the odds ratios were 2·3 (2·1–2·5) for uninsured patients and 3·3 (3·0–3·6) for Medicaid-insured patients compared with privately insured patients. Black and Hispanic patients were noted to have an increased risk of advanced-stage disease (stage III or IV) at diagnosis, irrespective of insurance status, compared with White patients. Interpretation: In this US-based analysis, uninsured and Medicaid-insured patients, and those from ethnic minorities, had substantially increased risks of presenting with advanced-stage cancers at diagnosis. Although many factors other than insurance status also affect the quality of care received, adequate insurance is a crucial factor for receiving appropriate cancer screening and timely access to medical care. [Copyright &y& Elsevier]
- Published
- 2008
- Full Text
- View/download PDF
37. Head and Neck Cancer Detection in Digitized Whole-Slide Histology Using Convolutional Neural Networks.
- Author
-
Halicek, Martin, Shahedi, Maysam, Little, James V., Chen, Amy Y., Myers, Larry L., Sumer, Baran D., and Fei, Baowei
- Subjects
- *
HEAD & neck cancer diagnosis , *ARTIFICIAL neural networks , *THYROID cancer , *SENTINEL lymph nodes , *PATHOLOGISTS - Abstract
Primary management for head and neck cancers, including squamous cell carcinoma (SCC), involves surgical resection with negative cancer margins. Pathologists guide surgeons during these operations by detecting cancer in histology slides made from the excised tissue. In this study, 381 digitized, histological whole-slide images (WSI) from 156 patients with head and neck cancer were used to train, validate, and test an inception-v4 convolutional neural network. The proposed method is able to detect and localize primary head and neck SCC on WSI with an AUC of 0.916 for patients in the SCC testing group and 0.954 for patients in the thyroid carcinoma testing group. Moreover, the proposed method is able to diagnose WSI with cancer versus normal slides with an AUC of 0.944 and 0.995 for the SCC and thyroid carcinoma testing groups, respectively. For comparison, we tested the proposed, diagnostic method on an open-source dataset of WSI from sentinel lymph nodes with breast cancer metastases, CAMELYON 2016, to obtain patch-based cancer localization and slide-level cancer diagnoses. The experimental design yields a robust method with potential to help create a tool to increase efficiency and accuracy of pathologists detecting head and neck cancers in histological images. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
38. Hyperspectral Imaging of Head and Neck Squamous Cell Carcinoma for Cancer Margin Detection in Surgical Specimens from 102 Patients Using Deep Learning.
- Author
-
Halicek, Martin, Dormer, James D., Little, James V., Chen, Amy Y., Myers, Larry, Sumer, Baran D., and Fei, Baowei
- Subjects
- *
HEAD & neck cancer diagnosis , *COLLECTION & preservation of biological specimens , *DIAGNOSTIC imaging , *LARYNX , *NASAL cavity , *HEAD & neck cancer , *PAPILLOMAVIRUS diseases , *PAPILLOMAVIRUSES , *SQUAMOUS cell carcinoma , *TONSILS , *RECEIVER operating characteristic curves , *DESCRIPTIVE statistics , *FLUORESCENT dyes , *OROPHARYNX , *DEEP learning - Abstract
Surgical resection of head and neck (H and N) squamous cell carcinoma (SCC) may yield inadequate surgical cancer margins in 10 to 20% of cases. This study investigates the performance of label-free, reflectance-based hyperspectral imaging (HSI) and autofluorescence imaging for SCC detection at the cancer margin in excised tissue specimens from 102 patients and uses fluorescent dyes for comparison. Fresh surgical specimens (n = 293) were collected during H and N SCC resections (n = 102). The tissue specimens were imaged with reflectance-based HSI and autofluorescence imaging and afterwards with two fluorescent dyes for comparison. A histopathological ground truth was made. Deep learning tools were developed to detect SCC with new patient samples (inter-patient) and machine learning for intra-patient tissue samples. Area under the curve (AUC) of the receiver-operator characteristic was used as the main evaluation metric. Additionally, the performance was estimated in mm increments circumferentially from the tumor-normal margin. In intra-patient experiments, HSI classified conventional SCC with an AUC of 0.82 up to 3 mm from the cancer margin, which was more accurate than proflavin dye and autofluorescence (both p < 0.05). Intra-patient autofluorescence imaging detected human papilloma virus positive (HPV+) SCC with an AUC of 0.99 at 3 mm and greater accuracy than proflavin dye (p < 0.05). The inter-patient results showed that reflectance-based HSI and autofluorescence imaging outperformed proflavin dye and standard red, green, and blue (RGB) images (p < 0.05). In new patients, HSI detected conventional SCC in the larynx, oropharynx, and nasal cavity with 0.85–0.95 AUC score, and autofluorescence imaging detected HPV+ SCC in tonsillar tissue with 0.91 AUC score. This study demonstrates that label-free, reflectance-based HSI and autofluorescence imaging methods can accurately detect the cancer margin in ex-vivo specimens within minutes. This non-ionizing optical imaging modality could aid surgeons and reduce inadequate surgical margins during SCC resections. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.